Absorption |
Blood-Brain Barrier | BBB- | 0.9748 |
Human Intestinal Absorption | HIA- | 0.9520 |
Caco-2 Permeability | Caco2- | 0.8957 |
P-glycoprotein Substrate | Substrate | 0.7260 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8942 |
Inhibitor | 0.5293 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8024 |
Distribution |
Subcellular localization | Mitochondria | 0.4446 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7943 |
CYP450 2D6 Substrate | Non-substrate | 0.8172 |
CYP450 3A4 Substrate | Substrate | 0.5374 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7538 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7088 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8666 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7034 |
CYP450 3A4 Inhibitor | Inhibitor | 0.6432 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5509 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9865 |
Non-inhibitor | 0.6145 |
AMES Toxicity | Non AMES toxic | 0.7336 |
Carcinogens | Non-carcinogens | 0.8392 |
Fish Toxicity | High FHMT | 0.9909 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9415 |
Honey Bee Toxicity | Low HBT | 0.6704 |
Biodegradation | Not ready biodegradable | 0.9968 |
Acute Oral Toxicity | III | 0.4938 |
Carcinogenicity (Three-class) | Non-required | 0.5045 |